blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2479286

EP2479286 - MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.09.2014
Database last updated on 24.04.2024
Most recent event   Tooltip15.07.2016Lapse of the patent in a contracting state
New state(s): TR
published on 17.08.2016  [2016/33]
Applicant(s)For all designated states
The Ohio State University Research Foundation
1524 North High Street
Columbus, OH 43201 / US
[2013/31]
Former [2012/30]For all designated states
The Ohio State University Research Foundation
1960 Kenny Road
Columbus, OH 43210-1063 / US
Inventor(s)01 / Croce, Carlo
2140 Cambridge Boulevard
Columbus, OH 43221 / US
02 / Calin, George
12210 Willow Brook Lane
Pearland, TX 77584-6534 / US
03 / Volinia, Stefano
Corso Piave, 17
44100 Ferrara / IT
 [2012/30]
Representative(s)Turner, Craig Robert
AA Thornton IP LLP
8th Floor, 125 Old Broad Street
London EC2N 1AR / GB
[N/P]
Former [2012/30]Turner, Craig Robert
A.A. Thornton & Co.
235 High Holborn
London WC1V 7LE / GB
Application number, filing date12154307.803.01.2007
[2012/30]
Priority number, dateUS20060756585P05.01.2006         Original published format: US 756585 P
[2012/30]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2479286
Date:25.07.2012
Language:EN
[2012/30]
Type: B1 Patent specification 
No.:EP2479286
Date:13.11.2013
Language:EN
[2013/46]
Search report(s)(Supplementary) European search report - dispatched on:EP26.06.2012
ClassificationIPC:C12Q1/68, G01N33/574
[2012/30]
CPC:
C12Q1/6886 (EP,CN,US); A61K31/7105 (EP,US); A61P35/00 (EP);
C12N15/111 (EP,US); C12N15/113 (EP,US); C12N2310/113 (US);
C12N2310/14 (EP,US); C12N2310/141 (US); C12N2320/11 (EP,US);
C12N2320/12 (EP,US); C12N2320/30 (US); C12N2330/10 (EP,US);
C12Q1/6837 (EP,US); C12Q2600/158 (EP,CN,US); C12Q2600/178 (EP,CN,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2012/30]
TitleGerman:Verfahren und Zusammensetzungen auf Mikro-RNA-Basis zur Diagnose und Behandlung von festen Krebsen[2012/30]
English:MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers[2012/30]
French:Procédés à base de micro ARN et compositions pour le diagnostic et le traitement des cancers solides[2012/30]
Examination procedure15.01.2013Examination requested  [2013/09]
20.02.2013Despatch of a communication from the examining division (Time limit: M04)
10.04.2013Reply to a communication from the examining division
04.06.2013Communication of intention to grant the patent
30.09.2013Fee for grant paid
30.09.2013Fee for publishing/printing paid
Parent application(s)   TooltipEP07717903.4  / EP1969147
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20070717903) is  29.01.2010
Opposition(s)14.08.2014No opposition filed within time limit [2014/43]
Fees paidRenewal fee
05.03.2012Renewal fee patent year 03
05.03.2012Renewal fee patent year 04
05.03.2012Renewal fee patent year 05
05.03.2012Renewal fee patent year 06
25.01.2013Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU03.01.2007
AT13.11.2013
BE13.11.2013
BG13.11.2013
CY13.11.2013
CZ13.11.2013
DK13.11.2013
EE13.11.2013
FI13.11.2013
LT13.11.2013
LV13.11.2013
MC13.11.2013
NL13.11.2013
PL13.11.2013
RO13.11.2013
SE13.11.2013
SI13.11.2013
SK13.11.2013
TR13.11.2013
IE03.01.2014
LU03.01.2014
GR14.02.2014
IS13.03.2014
PT13.03.2014
[2016/33]
Former [2016/32]HU03.01.2007
AT13.11.2013
BE13.11.2013
BG13.11.2013
CY13.11.2013
CZ13.11.2013
DK13.11.2013
EE13.11.2013
FI13.11.2013
LT13.11.2013
LV13.11.2013
MC13.11.2013
NL13.11.2013
PL13.11.2013
RO13.11.2013
SE13.11.2013
SI13.11.2013
SK13.11.2013
IE03.01.2014
LU03.01.2014
GR14.02.2014
IS13.03.2014
PT13.03.2014
Former [2016/28]AT13.11.2013
BE13.11.2013
BG13.11.2013
CY13.11.2013
CZ13.11.2013
DK13.11.2013
EE13.11.2013
FI13.11.2013
LT13.11.2013
LV13.11.2013
MC13.11.2013
NL13.11.2013
PL13.11.2013
RO13.11.2013
SE13.11.2013
SI13.11.2013
SK13.11.2013
IE03.01.2014
LU03.01.2014
GR14.02.2014
IS13.03.2014
PT13.03.2014
Former [2016/24]AT13.11.2013
BE13.11.2013
BG13.11.2013
CY13.11.2013
CZ13.11.2013
DK13.11.2013
EE13.11.2013
FI13.11.2013
LT13.11.2013
LV13.11.2013
MC13.11.2013
NL13.11.2013
PL13.11.2013
RO13.11.2013
SE13.11.2013
SI13.11.2013
SK13.11.2013
IE03.01.2014
LU03.01.2014
IS13.03.2014
PT13.03.2014
Former [2015/21]AT13.11.2013
BE13.11.2013
CY13.11.2013
CZ13.11.2013
DK13.11.2013
EE13.11.2013
FI13.11.2013
LT13.11.2013
LV13.11.2013
MC13.11.2013
NL13.11.2013
PL13.11.2013
SE13.11.2013
SI13.11.2013
SK13.11.2013
IE03.01.2014
LU03.01.2014
IS13.03.2014
PT13.03.2014
Former [2015/14]AT13.11.2013
BE13.11.2013
CY13.11.2013
CZ13.11.2013
DK13.11.2013
EE13.11.2013
FI13.11.2013
LT13.11.2013
LV13.11.2013
NL13.11.2013
PL13.11.2013
SE13.11.2013
SI13.11.2013
SK13.11.2013
IE03.01.2014
LU03.01.2014
IS13.03.2014
PT13.03.2014
Former [2015/07]AT13.11.2013
BE13.11.2013
CY13.11.2013
CZ13.11.2013
DK13.11.2013
EE13.11.2013
FI13.11.2013
LT13.11.2013
LV13.11.2013
NL13.11.2013
PL13.11.2013
SE13.11.2013
SK13.11.2013
IE03.01.2014
LU03.01.2014
IS13.03.2014
PT13.03.2014
Former [2014/41]AT13.11.2013
BE13.11.2013
CY13.11.2013
CZ13.11.2013
DK13.11.2013
EE13.11.2013
FI13.11.2013
LT13.11.2013
LV13.11.2013
NL13.11.2013
PL13.11.2013
SE13.11.2013
SK13.11.2013
LU03.01.2014
IS13.03.2014
PT13.03.2014
Former [2014/37]AT13.11.2013
BE13.11.2013
CY13.11.2013
CZ13.11.2013
EE13.11.2013
FI13.11.2013
LT13.11.2013
LV13.11.2013
NL13.11.2013
PL13.11.2013
SE13.11.2013
SK13.11.2013
IS13.03.2014
PT13.03.2014
Former [2014/36]AT13.11.2013
BE13.11.2013
CY13.11.2013
EE13.11.2013
FI13.11.2013
LT13.11.2013
LV13.11.2013
NL13.11.2013
SE13.11.2013
IS13.03.2014
PT13.03.2014
Former [2014/28]AT13.11.2013
BE13.11.2013
CY13.11.2013
FI13.11.2013
LT13.11.2013
LV13.11.2013
NL13.11.2013
SE13.11.2013
IS13.03.2014
PT13.03.2014
Former [2014/26]AT13.11.2013
BE13.11.2013
CY13.11.2013
FI13.11.2013
LT13.11.2013
LV13.11.2013
NL13.11.2013
SE13.11.2013
IS13.03.2014
Former [2014/25]AT13.11.2013
FI13.11.2013
LT13.11.2013
LV13.11.2013
NL13.11.2013
SE13.11.2013
IS13.03.2014
Former [2014/24]AT13.11.2013
FI13.11.2013
LT13.11.2013
NL13.11.2013
SE13.11.2013
IS13.03.2014
Former [2014/23]FI13.11.2013
LT13.11.2013
NL13.11.2013
SE13.11.2013
IS13.03.2014
Former [2014/22]FI13.11.2013
LT13.11.2013
NL13.11.2013
SE13.11.2013
Former [2014/20]LT13.11.2013
Documents cited:Search[A]  - IORIO MARILENA V ET AL, "MicroRNA gene expression deregulation in human breast cancer", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD., US, (20050801), vol. 65, no. 16, ISSN 0008-5472, pages 7065 - 7070, XP002457421 [A] 1-12 * tables 1,3 *

DOI:   http://dx.doi.org/10.1158/0008-5472.CAN-05-1783
 [A]  - JUN LU ET AL, "Micro RNA expression profiles classify human cancers", NATURE: INTERNATIONAL WEEKLY JOURNAL OF SCIENCE, NATURE PUBLISHING GROUP, UNITED KINGDOM, (20050609), vol. 435, no. 7043, doi:10.1038/NATURE03702, ISSN 0028-0836, pages 834 - 838, XP008125350 [A] 1-12

DOI:   http://dx.doi.org/10.1038/nature03702
by applicantUS5427916
 US2002086356
 US2004014113
 US5252479
 US5139941
 WO9413788
 WO9324641
 US2002173478
 US2004018176
 US5849902
 US4987071
 US4235871
 US4501728
 US4837028
 US5019369
 US4920016
    - JEMAL, A. ET AL., CA CANCER J CLIN., (2002), vol. 52, pages 23 - 47
    - SIMARD, J. ET AL., ENDOCRINOLOGY, (2002), vol. 143, no. 6, pages 2029 - 40
    - PESCHEL, R.E.; J.W. COLBERG, LANCET, (2003), vol. 4, pages 233 - 41
    - NELSON, W.G. ET AL., N. ENGL. J MED, (2003), vol. 349, no. 4, pages 366 - 81
    - PUNGLIA ET AL., N. ENGL. J MED, (2003), vol. 349, no. 4, pages 335 - 42
    - NATHANSON, K.L. ET AL., HUMAN MOL. GEN., (2001), vol. 10, no. 7, pages 715 - 720
    - BR. J CANCER, (2000), vol. 83, no. 10, pages 1301 - 08
    - SYRJAKOSKI, K. ET AL., J NATL. CANCER INST., (2000), vol. 92, pages 1529 - 31
    - BURR, H.A. ET AL., THE ONCOLOGIST, (2005), vol. 10, no. 3, pages 183 - 190
    - GOODMAN, G.E., THORAX, (2002), vol. 57, pages 994 - 999
    - CHENG, A.M. ET AL., NUCLEIC ACIDS RES., (2005), vol. 33, pages 1290 - 1297
    - ISHIZUKA, A. ET AL., GENES DEV, (2002), vol. 16, pages 2497 - 2508
    - CALIN, G.A. ET AL., PROC. NATL. ACAD. SCI. US.A., (2002), vol. 99, pages 15524 - 15529
    - RIGBY ET AL., J MOL. BIOL., (1977), vol. 113, pages 237 - 251
    - FIENBERG ET AL., ANAL. BIOCHEM., (1983), vol. 132, pages 6 - 13
    - ZENG ET AL., MOLECULAR CELL, (2002), vol. 9, pages 1327 - 1333
    - TUSCHL, NAT. BIOTECHNOL, (2002), vol. 20, pages 446 - 448
    - BRUMMELKAMP ET AL., SCIENCE, (2002), vol. 296, pages 550 - 553
    - MIYAGISHI ET AL., NAT. BIOTECHNOL., (2002), vol. 20, pages 497 - 500
    - PADDISON ET AL., GENES DEV., (2002), vol. 16, pages 948 - 958
    - LEE ET AL., NAT. BIOTECHNOL., (2002), vol. 20, pages 500 - 505
    - PAUL ET AL., NAT. BIOTECHNOL., (2002), vol. 20, pages 505 - 508
    - RABINOWITZ, J.E. ET AL., J VIROL., (2002), vol. 76, pages 791 - 801
    - DORNBURG, GENE THERAPY, (1995), vol. 2, pages 301 - 310
    - EGLITIS, BIOTECHNIQUES, (1988), vol. 6, pages 608 - 614
    - MILLER, HUM. GENE THERAPY, (1990), vol. 1, pages 5 - 14
    - ANDERSON, NATURE, (1998), vol. 392, pages 25 - 30
    - XIA ET AL., NAT. BIOTECH., (2002), vol. 20, pages 1006 - 1010
    - SAMULSKI ET AL., J VIROL., (1987), vol. 61, pages 3096 - 3101
    - FISHER ET AL., J. VIROL., (1996), vol. 70, pages 520 - 532
    - SAMULSKI ET AL., J VIROL., (1989), vol. 63, pages 3822 - 3826
    - STEIN; CHENG, SCIENCE, (1993), vol. 261, page 1004
    - WERNER; UHLENBECK, NUCL. ACIDS RES., (1995), vol. 23, pages 2092 - 96
    - HAMMANN ET AL., ANTISENSE AND NUCLEIC ACID DRUG DEV., (1999), vol. 9, pages 25 - 31
    - SZOKA ET AL., ANN. REV. BIOPHYS. BIOENG, (1980), vol. 9, page 467
    - GABIZON ET AL., PROC. NATL. ACAD. SCI., U.S.A., (1988), vol. 18, pages 6949 - 53
    - LIU, C.-G. ET AL., PROC. NATL. ACAD. SCI. USA, (2004), vol. 101, pages 11755 - 11760
    - CALIN, G.A. ET AL., PROC. NATL. ACAD SCI. USA, (2004), vol. 101, pages 11755 - 11760
    - IORIO, M.V. ET AL., CANCER RES., (2005), vol. 65, pages 7065 - 7070
    - GRIFFITHS-JONES, S., NUCLEIC ACIDS RES, (2004), vol. 32, pages D109 - 11
    - TUSHER, V. G. ET AL., PROC NATL ACAD SCI USA, (2001), vol. 98, pages 5116 - 21
    - JUNG, S. H. ET AL., BIOSTATISTICS, (2005), vol. 6, pages 157 - 69
    - LU, J. ET AL., NATURE, (2005), vol. 435, pages 834 - 8
    - HE, L. ET AL., NATURE, (2005), vol. 435, pages 828 - 833
    - CHAN, J.A. ET AL., CANCER RES., (2005), vol. 65, pages 6029 - 6033
    - EIS, P.S. ET AL., PROC. NATL. ACAD SCI. USA, (2005), vol. 102, pages 3627 - 3632
    - METZLER, M. ET AL., GENES CHROMOSOMES CANCER, (2004), vol. 39, pages 167 - 169
    - LEWIS, B.P. ET AL., CELL, (2005), vol. 120, pages 15 - 20
    - ALI, A.A. ET AL., FASEB J., (1993), vol. 7, pages 931 - 937
    - BUCK, M.B. ET AL., CLIN. CANCER RES., (2004), vol. 10, pages 491 - 498
    - BISWAS, S. ET AL., CANCER RES., (2004), vol. 64, pages 687 - 692
    - JOHNSON, S.M. ET AL., CELL, (2005), vol. 120, pages 635 - 647
    - O'DONNELL, K.A. ET AL., NATURE, (2005), vol. 435, pages 839 - 843
    - CIMMINO, A. ET AL., PROC. NATL. ACAD. SCI. USA, (2005), vol. 102, pages 13944 - 13949
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.